Equus Subsidiary, Morgan E&P, Secures $3 Million Term Loan to Advance Drilling and Work-Over Program in North Dakota's Williston Basin
Equus Total Return, Inc. Funding Announcement: Equus announced that its subsidiary, Morgan E&P, has secured a $3 million term loan to fund drilling operations in the Bakken Shale formation, aiming to enhance production and cash flow by developing existing non-producing wells.
Strategic Development Plans: The funding will allow Morgan to accelerate development opportunities in both operated and non-operated acreage, with expectations of increasing production volumes and strengthening Equus' energy portfolio strategy in one of North America's key oil-producing regions.
Trade with 70% Backtested Accuracy
Analyst Views on EQS
About EQS
About the author

- Acquisition of Erevo: Equasens has acquired an 80% controlling stake in Erevo, expected to generate €7.4 million in revenue by 2025, significantly enhancing its market position in healthcare professional training.
- Training Product Expansion: This acquisition integrates Erevo's online courses with Equasens' existing services, improving training quality and addressing the healthcare industry's demand for continuous education, which is anticipated to boost customer satisfaction and market share.
- Synergies Realized: Erevo's digital training solutions complement Equasens' hardware and software offerings, expected to create substantial operational and marketing synergies that support the company's growth in the rapidly evolving healthcare education market.
- Future Development Potential: By leveraging Erevo's expertise, Equasens plans to develop new AI-driven features to enhance educational effectiveness, ensuring its leadership position in the healthcare training sector.
- Financial Calendar Release: Equasens announces its financial calendar for FY 2026, with 2025 annual revenue set to be released on February 5, 2026, reflecting the company's commitment to transparency and aiming to bolster investor confidence.
- Earnings Report Schedule: The 2025 annual results will be published on March 30, 2026, followed by the Q1 2026 revenue report, which is expected to provide critical performance metrics that will help the market assess the company's future growth potential.
- Annual General Meeting Date: The company plans to hold its Annual General Meeting on June 25, 2026, aiming to enhance communication with shareholders and promote corporate governance and transparency.
- Commitment to Sustainable Development: As a leader in digital healthcare solutions, Equasens is dedicated to supporting healthcare professionals through regular financial disclosures, further solidifying its leadership position in the industry.
- ABS Transaction Overview: KBRA assigns preliminary ratings to three classes of notes issued by OWN Equipment Fund III LLC, marking EquipmentShare.com Inc.'s fourth equipment rental ABS transaction as Equipment Manager, indicating its ongoing activity in the market.
- Funding Structure: The transaction's funding is secured through a lease agreement between EquipmentShare and the issuer, where EQS pays a variable lease payment based on customer rental fees, ensuring initial cash flow for noteholders.
- Partnership Dynamics: The other co-sponsor for this transaction is the newly formed OWN Tactical Equipment III LLC, managed by MidOcean Credit Fund Management LP, highlighting EquipmentShare's strategic partnership expansion in the equipment rental market.
- Market Impact: Through this ABS transaction, EquipmentShare not only enhances its financing capabilities but also solidifies its market position in the equipment rental industry, which is expected to positively influence its future business growth.
- Net Asset Decline: As of September 30, 2025, Equus reported net assets of $26.5 million, a 16.5% decrease from $34.1 million on June 30, 2025, indicating a deterioration in financial health that may impact investor confidence.
- Decrease in Net Asset Value per Share: The net asset value per share fell from $2.51 on June 30, 2025, to $1.90, a 24.3% drop, suggesting increased market pressures that could lead to reduced shareholder returns.
- Loss on GEVI Investment: Equus saw the value of its investment in General Enterprise Ventures decrease from $10.6 million to $5.2 million during Q3, a 54.7% decline, reflecting adverse performance in high-risk investments that may affect future investment strategies.
- Stability in Morgan E&P: Despite a downturn in the oil and gas market, Equus maintained its investment value in Morgan E&P at $12.35 million, indicating stability in this sector that could support future growth opportunities.

Equus Total Return, Inc. Funding Announcement: Equus announced that its subsidiary, Morgan E&P, has secured a $3 million term loan to fund drilling operations in the Bakken Shale formation, aiming to enhance production and cash flow by developing existing non-producing wells.
Strategic Development Plans: The funding will allow Morgan to accelerate development opportunities in both operated and non-operated acreage, with expectations of increasing production volumes and strengthening Equus' energy portfolio strategy in one of North America's key oil-producing regions.

Equus Total Return, Inc. Compliance Issue: The company received a notice from the NYSE for not meeting the minimum average closing price requirement of $1.00 for its common stock over a 30-day period, but this deficiency does not currently affect its listing or trading status.
Plans to Regain Compliance: Equus intends to notify the NYSE by May 25, 2025, of its plan to address the stock price deficiency, potentially through a reverse stock split, and has a six-month period to regain compliance with the NYSE's standards.








